Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Columbus, Ohio 43210

0 studies enrolling now · 2 studies all time

What they study most

Acute Myeloid Leukemia, Lymphoma, Non-Hodgkin

Studies at this site

• Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy — Completed
• Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments — Completed